An active tumor-targeting organic photochemotherapy agent with naproxen for enhanced cancer therapy

An active tumor-targeting organic photochemotherapy agent via the combination of a an organic photothermal material and a naproxen prodrug was developed to precisely kill cancer cells and suppress the inflammatory response induced by cell necrosis; in vitro, and in vivo experiments illustrated its low cytotoxicity and excellent tumor inhibitory effect.

Automated summary

This new active tumor-targeting organic photochemotherapy agent combines an organic photothermal material with a naproxen prodrug to precisely kill cancer cells and suppress inflammatory responses. In vitro and in vivo experiments have shown its low cytotoxicity and excellent tumor inhibitory effect.